Overall, this study highlights the importance of PAFR signaling in miR-149-5p-mediated effects in NSCLC cells and thus demonstrates the need for further exploration of this axis in relation to the therapeutic potential of targeted therapy in experimental lung cancer models. Here, PTAFR is linked to non-small cell lung carcinoma.